Viewing Study NCT00611468


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-02-23 @ 6:27 AM
Study NCT ID: NCT00611468
Status: COMPLETED
Last Update Posted: 2011-08-22
First Post: 2008-01-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors
Sponsor:
Organization: